GLP-1 is the hot topics at the moment. But how do we know it’s more than just a fad? And could the emergence of GLP-1 drugs be leading to other, less pharmaceutical, innovations in the food industry?

In this episode of the Food Matters Live podcast, recorded at our Rotterdam event, a panel of experts explain why the eveidence suggests GLP-1 medications do represent a true, long-term disruption. 

With tens-of-millions of people already using the drugs, our speakers suggest we are already seeing consumer spending shifting away from junk food.

How the industry responds will be critical, and there is an opportunity for brands targeting a more health-curious demographic.

Collagen peptides that trigger natural GLP-1 secretion are already gaining attention as an alternative to daily injections, what else could be in store remains to be seen.